Literature DB >> 30969500

Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.

Ondine Walter1, Emmanuel Treiner2, Fabrice Bonneville1, Catherine Mengelle1, François Vergez3, Fleur Lerebours1, Pierre Delobel1, Roland Liblau2, Guillaume Martin-Blondel4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30969500     DOI： 10.1056/NEJMc1816198

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.

Authors:  Aabha Oza; Michael P Rettig; Phil Powell; Kathryn O'Brien; David B Clifford; Julie Ritchey; Leah Gehrs; Julia Hollaway; Eugene Major; Todd A Fehniger; Christopher A Miller; Patrick Soon-Shiong; Amy Rock; John F DiPersio
Journal:  Blood Adv       Date:  2020-06-09

2.  PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Ann Transl Med       Date:  2019-12

3.  Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Authors:  Daniele Focosi; Marco Tuccori; Fabrizio Maggi
Journal:  Ann Transl Med       Date:  2019-12

4.  Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy.

Authors:  Julien Haroche; Fleur Cohen Aubart; Karima Mokhtari; Danielle Seilhean; Neila Benameur; Matthieu Peyre; Ahmed Idbaih; Zahir Amoura
Journal:  Neurol Clin Pract       Date:  2021-06

Review 5.  Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.

Authors:  Sydney Corey; Bryan R Smith; Irene C M Cortese
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-01       Impact factor: 5.495

6.  Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report.

Authors:  Strachan Mackenzie; Manar Shafat; Harriet Roddy; Harpreet Hyare; Lorna Neill; Maria A V Marzolini; Michael Gilhooley; Teresa Marafioti; Eleanna Kara; Emilie Sanchez; Jeremy Rees; David S Lynch; Kirsty Thomson; Kirit M Ardeshna; Arian Laurence; Karl S Peggs; Maeve O'Reilly; Claire Roddie
Journal:  EJHaem       Date:  2021-08-04

Review 7.  Advances in Treatment of Progressive Multifocal Leukoencephalopathy.

Authors:  Raphaël Bernard-Valnet; Igor J Koralnik; Renaud Du Pasquier
Journal:  Ann Neurol       Date:  2021-09-07       Impact factor: 11.274

8.  PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy.

Authors:  Nora Möhn; Mike P Wattjes; Ortwin Adams; Sandra Nay; Daria Tkachenko; Friederike Salge; Johanne Heine; Kaweh Pars; Günter Höglinger; Gesine Respondek; Martin Stangel; Thomas Skripuletz; Roland Jacobs; Kurt-Wolfram Sühs
Journal:  Ther Adv Neurol Disord       Date:  2021-03-09       Impact factor: 6.570

9.  Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy.

Authors:  Franziska Hopfner; Nora Möhn; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Jens Gottlieb; Rainer Blasczyk; Nima Mahmoudi; Kaweh Pars; Ortwin Adams; Martin Stangel; Mike P Wattjes; Günter Höglinger; Thomas Skripuletz
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-17

Review 10.  Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.

Authors:  S Richard Dunham; Robert Schmidt; David B Clifford
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.